Clinical Trial Update: Standard Systemic Therapy Combined With High/Low-dose Radiotherapy Plus Toripalimab for Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating standard systemic therapy plus high/low-dose radiotherapy and toripalimab for microsatellite-stable metastatic colorectal canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Fudan University | Conditions: Microsatellite Stable Metastatic Colorectal Cancer | Phase 2 | Status: RECRUITING